[
  {
    "ts": null,
    "headline": "A Fresh Look at Revvity’s (RVTY) Valuation After Q3 Earnings, Outlook Update, and $1 Billion Buyback",
    "summary": "Revvity (NYSE:RVTY) just released its third-quarter earnings, with sales ticking higher while net income came in below last year. The company also updated its full-year outlook to reflect currency changes and announced a major share buyback program. See our latest analysis for Revvity. Revvity’s string of updates, including its $1 billion share buyback and solid sales growth, have helped the stock regain some momentum after a tough year. While the 90-day share price return is up 3.2%, the...",
    "url": "https://finnhub.io/api/news?id=56d351e685f2989d619fd85531f307412ce3d319ed61a436b10a6d03fbd60760",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762809103,
      "headline": "A Fresh Look at Revvity’s (RVTY) Valuation After Q3 Earnings, Outlook Update, and $1 Billion Buyback",
      "id": 137438168,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "Revvity (NYSE:RVTY) just released its third-quarter earnings, with sales ticking higher while net income came in below last year. The company also updated its full-year outlook to reflect currency changes and announced a major share buyback program. See our latest analysis for Revvity. Revvity’s string of updates, including its $1 billion share buyback and solid sales growth, have helped the stock regain some momentum after a tough year. While the 90-day share price return is up 3.2%, the...",
      "url": "https://finnhub.io/api/news?id=56d351e685f2989d619fd85531f307412ce3d319ed61a436b10a6d03fbd60760"
    }
  },
  {
    "ts": null,
    "headline": "Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy",
    "summary": "WALTHAM, Mass., November 10, 2025--Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the National Institute of Standards and Technology (NIST) as part of the Somatic Reference Samples (SRS) Initiative.",
    "url": "https://finnhub.io/api/news?id=4e28600f042615c446e0d43f588de1d126f9e9e507b86a2006020a23ce10b867",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762779600,
      "headline": "Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy",
      "id": 137395476,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "WALTHAM, Mass., November 10, 2025--Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the National Institute of Standards and Technology (NIST) as part of the Somatic Reference Samples (SRS) Initiative.",
      "url": "https://finnhub.io/api/news?id=4e28600f042615c446e0d43f588de1d126f9e9e507b86a2006020a23ce10b867"
    }
  },
  {
    "ts": null,
    "headline": "Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities",
    "summary": "WALTHAM, Mass., November 10, 2025--Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end markets. This acquisition expands the breadth and depth of Revvity Signals’ solutions for bridging the gap between analytical data and actionable insights, further strengthening its ability to acc",
    "url": "https://finnhub.io/api/news?id=bb909142d17d0288d59c2eb236f9afcbfaa4d38d4afbeb5d66a9e1eeb0c39251",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762778700,
      "headline": "Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities",
      "id": 137395477,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "WALTHAM, Mass., November 10, 2025--Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end markets. This acquisition expands the breadth and depth of Revvity Signals’ solutions for bridging the gap between analytical data and actionable insights, further strengthening its ability to acc",
      "url": "https://finnhub.io/api/news?id=bb909142d17d0288d59c2eb236f9afcbfaa4d38d4afbeb5d66a9e1eeb0c39251"
    }
  },
  {
    "ts": null,
    "headline": "Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript",
    "summary": "Revvity, Inc. (RVTY) UBS Global Healthcare Conference 2025 November 10, 2025 8:00 AM ESTCompany ParticipantsMaxwell Krakowiak - Senior VP &...",
    "url": "https://finnhub.io/api/news?id=aa3dde3553626d548fd4d9c3f8aef56bad17e24d274afdd41ee23dcd50d833f6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762769500,
      "headline": "Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript",
      "id": 137394645,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "RVTY",
      "source": "SeekingAlpha",
      "summary": "Revvity, Inc. (RVTY) UBS Global Healthcare Conference 2025 November 10, 2025 8:00 AM ESTCompany ParticipantsMaxwell Krakowiak - Senior VP &...",
      "url": "https://finnhub.io/api/news?id=aa3dde3553626d548fd4d9c3f8aef56bad17e24d274afdd41ee23dcd50d833f6"
    }
  },
  {
    "ts": null,
    "headline": "3 Cash-Producing Stocks That Fall Short",
    "summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
    "url": "https://finnhub.io/api/news?id=a550edf5212c42f859145d1e2d81237f92146b695426cb3a75ba661d83f72f5f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762750006,
      "headline": "3 Cash-Producing Stocks That Fall Short",
      "id": 137395478,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
      "url": "https://finnhub.io/api/news?id=a550edf5212c42f859145d1e2d81237f92146b695426cb3a75ba661d83f72f5f"
    }
  }
]